The pharmaceutical industry generates wastewater that is often highly complex, containing diverse organic compounds, active pharmaceutical ingredients (APIs), and sometimes even resistant pollutants. Effective remediation of such wastewater is not just an environmental imperative but also a regulatory necessity. Polyaluminium Chloride (PAC 30% Al2O3) provides a robust and efficient solution for these challenging treatment scenarios.


NINGBO INNO PHARMCHEM CO.,LTD. is a dedicated Polyaluminium Chloride PAC 30% Al2O3 supplier, offering a product tailored to the stringent demands of pharmaceutical wastewater remediation. Our PAC 30% Al2O3 acts as a highly effective coagulant and flocculant, capable of breaking down stable suspensions and removing suspended solids, colloidal impurities, and even certain dissolved organic compounds that contribute to COD. This high-efficiency flocculant for water purification is designed to handle the unique composition of pharmaceutical effluents.


The key benefits of PAC 30% Al2O3 in water treatment for the pharmaceutical sector include its superior performance over a wide pH range, which is crucial given the varied pH of pharmaceutical wastewater. It rapidly forms large, dense flocs that settle quickly, accelerating the purification process and reducing the footprint of treatment facilities. Furthermore, it results in significantly less sludge volume compared to traditional coagulants, leading to lower disposal costs—a critical factor for pharmaceutical companies looking to optimize expenses. If you are seeking to buy Polyaluminium Chloride PAC 30% Al2O3, consider the comprehensive advantages it offers in managing complex waste streams.


By choosing Polyaluminium Chloride (PAC 30% Al2O3) from NINGBO INNO PHARMCHEM CO.,LTD., pharmaceutical manufacturers can enhance their wastewater treatment efficiency, ensure compliance with strict discharge regulations, and contribute to a cleaner environment. Our PAC 30% Al2O3 for wastewater treatment provides a reliable and cost-effective approach to managing challenging effluents, reinforcing sustainable practices within the pharmaceutical industry.